395 related articles for article (PubMed ID: 11728274)
1. Prevention of sudden cardiac death.
Goldberger JJ
Heart Dis; 2000; 2(4):305-13. PubMed ID: 11728274
[TBL] [Abstract][Full Text] [Related]
2. Treatment and prevention of sudden cardiac death: effect of recent clinical trials.
Goldberger JJ
Arch Intern Med; 1999 Jun; 159(12):1281-7. PubMed ID: 10386504
[TBL] [Abstract][Full Text] [Related]
3. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
Siddiqui A; Kowey PR
Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
[TBL] [Abstract][Full Text] [Related]
4. Treatment and prevention of sudden cardiac death--what have we learnt from randomised clinical trials?
Kam RM; Teo WS; Koh TH; Lim YL
Singapore Med J; 1999 Nov; 40(11):707-10. PubMed ID: 10709412
[TBL] [Abstract][Full Text] [Related]
5. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
Klein MH; Gold MR
Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
[TBL] [Abstract][Full Text] [Related]
6. [The patient at risk of sudden death:value of drug therapy].
Bonhorst D
Rev Port Cardiol; 2000 Feb; 19(2):233-9. PubMed ID: 10763353
[TBL] [Abstract][Full Text] [Related]
7. A guide to device selection: cardiac resynchronization therapy alone or in combination with an implantable cardioverter defibrillator.
Prystowsky EN
Rev Cardiovasc Med; 2003; 4 Suppl 2():S47-54. PubMed ID: 12776013
[TBL] [Abstract][Full Text] [Related]
8. [The implantable cardioverter/defibrillator].
Kuck KH; Siebels J; Schlüter M; Meinertz T
Herz; 1994 Oct; 19(5):287-93. PubMed ID: 8001901
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
10. Ventricular tachycardia and sudden cardiac death.
Reddy PC; Tandon N; Stafford PR
J La State Med Soc; 1999 May; 151(5):281-7. PubMed ID: 10363484
[TBL] [Abstract][Full Text] [Related]
11. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
Alboni P
Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
[TBL] [Abstract][Full Text] [Related]
12. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
[TBL] [Abstract][Full Text] [Related]
13. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM
J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003
[TBL] [Abstract][Full Text] [Related]
14. [Antiarrhythmic agents in the prevention of sudden cardiac death].
Halawa B
Pol Merkur Lekarski; 1999 Mar; 6(33):117-20. PubMed ID: 10365592
[TBL] [Abstract][Full Text] [Related]
15. Sudden death and hypertrophic cardiomyopathy: a review.
Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
[TBL] [Abstract][Full Text] [Related]
16. [Primary prevention of sudden cardiac death implanted cardioverter defibrillator (ICD) versus antiarrhythmic drugs].
Iturralde Torres P
Arch Cardiol Mex; 2007; 77 Suppl 4():S4-129-32. PubMed ID: 18938711
[TBL] [Abstract][Full Text] [Related]
17. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.
Tung R; Zimetbaum P; Josephson ME
J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736
[TBL] [Abstract][Full Text] [Related]
18. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
Ho AT; Pai SM; Timothy P; Pai RG
Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
[TBL] [Abstract][Full Text] [Related]
19. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
[TBL] [Abstract][Full Text] [Related]
20. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
Ostman-Smith I
Fundam Clin Pharmacol; 2010 Oct; 24(5):637-52. PubMed ID: 20727015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
